ClearPoint Neuro, Inc.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-25.5M | $-18.9M | $-22.1M | $-16.4M | $-14.4M | $-6.8M | $-5.5M | $-6.2M |
| Depreciation & Amortization | $814.0K | $980.0K | $626.0K | $244.0K | $159.0K | $334.0K | $144.0K | $109.4K |
| Depreciation | $400.0K | $200.0K | — | — | — | — | — | — |
| Amortization | $168.0K | $0 | — | — | — | — | — | — |
| Stock-Based Compensation | $8.2M | $6.9M | $6.1M | $4.1M | $2.1M | $1.1M | $799.0K | $1.2M |
| Net Cash from Operating Activities | $-23.9M | $-9.0M | $-13.7M | $-16.2M | $-12.7M | $-7.8M | $-2.9M | $-4.6M |
| Investing Activities | ||||||||
| Capital Expenditures | $522.0K | $275.0K | $717.0K | $253.0K | $168.0K | $41.0K | $10.0K | $63.5K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $615.0K | $-275.0K | $8.9M | $-10.7M | $-168.0K | $-482.0K | $-160.0K | $-63.5K |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $50.2M | $6.2M | $296.0K | $409.0K | $46.9M | $22.7M | $5.6M | $-1.5M |
| Net Change in Cash | $26.9M | $-3.0M | $-4.5M | $-26.5M | $34.0M | $14.4M | $2.6M | $-6.2M |
| Free Cash Flow | $-24.4M | $-9.2M | $-14.4M | $-16.4M | $-12.9M | $-7.8M | $-2.9M | $-4.7M |